The newly adopted Spanish National Strategy on Addiction 2017-24 links scientific evidence, quality and evaluation. For example, quality and evidence constitute two of the eight guiding principles, and evaluation and quality are one of six transversal areas. These principles are strategic objectives within the different action areas. The Autonomous Community Drugs/Addictions Plans also explicitly address quality within their strategies and action plans, particularly in recent years.
At the national level, there is no accreditation system for interventions in demand reduction. At autonomous community level, there are large differences between autonomous communities and action areas. Accreditation criteria are in place at community level for harm reduction and for use of opioids for harm reduction purpose. In the field of prevention, quality assurance is less systematised. Evaluation criteria may also differ between the communities.
All the autonomous community drug plans provide for training activities for professionals, aimed primarily at municipal prevention technicians and healthcare service professionals. Five autonomous communities offer university master’s courses on drug dependency and seven offer postgraduate courses. The main non-governmental organisations also have continuous training plans for their staff.
The European Drug Prevention Quality Standards, and many related materials (training courses, implementation guides, etc.), have been translated and adapted.